Acetylcholinesterase inhibitor SDZ ENA 713 (Rivastigmine) increases brain pyrrolidone carboxyl peptidase activity

Author： Ramrez-Exposito M.J.   Robert-Baudouy J.   Mayas M.D.   Garca M.J.   Ramrez M.   Martnez-Martos J.M.  

Publisher： Elsevier

ISSN： 0924-977X

Source： European Neuropsychopharmacology, Vol.11, Iss.5, 2001-10, pp. : 381-383

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Rivastigmine, a brain-region selective acetylcholinesterase inhibitor for treating Alzheimer’s disease: review and current status

By Gottwald M.D.   Rozanski R.I.  

Expert Opinion on Investigational Drugs, Vol. 8, Iss. 10, 1999-10 ,pp. : 1673-1682

Informa Healthcare

Access to resources Recommend Favorite

Safety and tolerance of ENA 713 in Alzheimer's disease (AD)

By Cutler N.R.   Sramek J.J.   Anand R.  

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 382-383

Elsevier

Access to resources Recommend Favorite

Immobilization stress-induced changes in brain acetylcholinesterase activity and cognitive function in mice

By Das A.   Kapoor K.   Sayeepriyadarshini A.T.   Dikshit M.   Palit G.   Nath C.  

Pharmacological Research, Vol. 42, Iss. 3, 2000-09 ,pp. : 213-217

Academic Press

Access to resources Recommend Favorite

Review of the acetylcholinesterase inhibitor galanthamine

By Sramek J.J.   Frackiewicz E.J.   Cutler N.R.  

Expert Opinion on Investigational Drugs, Vol. 9, Iss. 10, 2000-10 ,pp. : 2393-2402

Informa Healthcare

Access to resources Recommend Favorite

Central Selective Acetylcholinesterase Inhibitor with Neurotrophic Activity Structure-Activity Relationships of TAK-147 and Related Compounds

By  

Current Medicinal Chemistry, Vol. 7, Iss. 3, 2000-03 ,pp. : 341-354

Bentham Science Publishers

Access to resources Recommend Favorite